Manipulation of MYC, NPM1, and BIRC5 present well-defined roles in leukemogenic transformation, and CD69 expression on CLL cells has been discussed as a critical marker for predicting CLL prognosis45. Here, MYC is linked to B-cell chronic lymphocytic leukemia.